TB-0203 — Effect of High Dosage of AEA on Compressive Strength Technical Bulletin

/ concrete / mix design

There is no standard addition rate for air-entraining agents (AEA), such as DARAVAIR® and DAREX®. The amount of AEA needed depends upon the level of the air required and the many factors that effect the process of entraining air (see technical bulletin “Factors Affecting Air Entrainment,” TB-0200). When it is necessary to increase the addition rate of AEA to compensate for one or more inhibiting influences, questions are often raised regarding the chemical influence of the concrete admixture on the strength of the concrete.

Since DARAVAIR® and DAREX® AEAs do not participate in the hydration of Portland cement, it will not chemically affect the rate or level of strength development in the concrete, as long as the air content remains constant. To illustrate this, three test concretes were prepared in the laboratory using 50 mL/100 kg, 200 mL/100 kg and 650 mL/100 kg (0.75, 3.0 and 10.0 oz/100 lbs respectively) by weight of cement. In order to keep the air contents at essentially the same level, the concretes admixed at the 200 mL/100 kg and 650 mL/100 kg (3.0 and 10 oz/100 lbs) levels were subjected to excessive vibration prior to test for air content and the molding of cylinders.

The test data, which are summarized in the following table, show that the compressive strength of concrete is not affected, at constant air levels, in spite of the abnormally large quantities of AEA. The slightly higher strengths reported for the 650 mL addition rate concrete are mainly due to the lower air content.

Comparison of AEA Dosage to Compressive Strength of Concrete

        Compressive Strength, MPa (psi) @
DAREX AEA, mL/100 kg (oz/100 lbs) W/C Slump, mm (in.) Air, %  28 Days
50 (0.75) 0.55 95 (3.75) 4.8  29 (4250)
200 (3.0) 0.56 90 (3.50) 4.8 30 (4380)
650 (10) 0.55 90 (3.50) 4.4  31 (4475)

gcpat.com | North America Customer Service: 1 877-4AD-MIX1 (1 877-423-6491)

We hope the information here will be helpful. It is based on data and knowledge considered to be true and accurate and is offered for consideration, investigation and verification by the user, but we do not warrant the results to be obtained. Please read all statements, recommendations and suggestions in conjunction with our conditions of sale, which apply to all goods supplied by us. No statement, recommendation, or suggestion is intended for any use that would infringe any patent, copyright, or other third party right.

DARAVAIR and DAREX are  trademarks, which may be registered in the United States and/or other countries, of GCP Applied Technologies Inc. This trademark list has been compiled using available published information as of the publication date and may not accurately reflect current trademark ownership or status.

© Copyright 2018 GCP Applied Technologies Inc. All rights reserved.

GCP Applied Technologies Inc., 62 Whittemore Avenue, Cambridge, MA 02140 USA.

In Canada, 294 Clements Road, West, Ajax, Ontario, Canada L1S 3C6.

This document is only current as of the last updated date stated below and is valid only for use in the United States. It is important that you always refer to the currently available information at the URL below to provide the most current product information at the time of use. Additional literature such as Contractor Manuals, Technical Bulletins, Detail Drawings and detailing recommendations and other relevant documents are also available on www.gcpat.com. Information found on other websites must not be relied upon, as they may not be up-to-date or applicable to the conditions in your location and we do not accept any responsibility for their content. If there are any conflicts or if you need more information, please contact GCP Customer Service.

Last Updated: 2020-03-09

https://gcpat.com/en/solutions/products/tb-0203-effect-high-dosage-aea-compressive-strength-technical-bulletin